Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
ACS chemical neuroscience
2025
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/41329964/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Exploring the Protective Effects of Two Alkaloids and from C23-3 on Neuronal Cells by Combining Bioinformatics Prediction and Experimental Verification. Chen, Minqi Tang, Guangming Zhang, Yi Qian, Zhong-Ji Aspergillus Alkaloids Neurons Animals Neuroprotective Agents Molecular Docking Simulation Apoptosis Mice Glycogen Synthase Kinase 3 beta Computational Biology Phosphorylation Cell Line Cell Survival Alzheimer's disease (AD) is an irreversible neurodegenerative disease that can lead to brain cell death and brain atrophy, manifested as memory loss, cognitive decline, and behavioral abnormalities. Its mechanism is complex, and there is currently no effective treatment method. The search for new therapies and natural drug candidates has become the focus of research. In recent years, marine-derived strains of have become an important research direction for treating AD due to the unique structure and biological activity of their secondary metabolites. In this study, we investigated the potential of two alkaloids from C23-3 in the treatment of AD through bioinformatics analysis and experimental validation. Bioinformatics analyses showed that the two alkaloids may act by modulating key targets associated with AD, especially alkaloid , which may exert significant therapeutic effects on AD by inhibiting glycogen synthase kinase-3β (GSK-3β) activity and reducing the level of hyperphosphorylation of Tau proteins. Molecular docking experiments showed that alkaloids and formed stable complexes with GSK-3β with a high affinity. Cellular experiments showed that alkaloids and could effectively inhibit apoptosis and injury in HT-22 cells. Further studies showed that alkaloid reduced the phosphorylation level of Tau protein and attenuated oxidative-stress-induced neurological injury by inhibiting GSK-3β and its related pathways. These results suggest that alkaloid has significant potential for AD therapy.